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Inhibitory neurons are critical for regulating effective transfer of sensory information and
network stability. The precision of inhibitory function likely derives from the existence
of a variety of interneuron subtypes. Their specification is largely dependent on the
locale of origin of interneuron progenitors. Neocortical and hippocampal inhibitory neurons
originate the subpallium, namely in the medial and caudal ganglionic eminences (MGE and
CGE), and in the preoptic area (POA). In the hippocampus, neuronal nitric oxide synthase
(nNOS)-expressing cells constitute a numerically large GABAergic interneuron population.
On the contrary, nNOS-expressing inhibitory neurons constitute the smallest of the known
neocortical GABAergic neuronal subtypes. The origins of most neocortical GABAergic
neuron subtypes have been thoroughly investigated, however, very little is known about
the origin of, or the genetic programs underlying the development of nNOS neurons. Here,
we show that the vast majority of neocortical nNOS-expressing neurons arise from the
MGE rather than the CGE. Regarding their molecular signature, virtually all neocortical
nNOS neurons co-express the neuropeptides somatostatin (SST) and neuropeptide Y
(NPY), and about half of them express the calcium-binding protein calretinin (CR). nNOS
neurons thus constitute a small cohort of the MGE-derived SST-expressing population of
cortical inhibitory neurons. Finally, we show that conditional removal of the transcription
factor Sox6 in MGE-derived GABAergic cortical neurons results in an absence of SST and
CR expression, as well as reduced expression of nNOS in neocortical nNOS neurons.
Based on their respective abundance, origin and molecular signature, our results suggest
that neocortical and hippocampal nNOS GABAergic neurons likely subserve different
functions and have very different physiological relevance in these two cortical structures.
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INTRODUCTION
Brain activity is regulated by the interaction of two major types
of neural cells: excitatory neurons that use the neurotransmitter
glutamate and inhibitory neurons that use the neurotransmit-
ter γ-aminobutyric acid (GABA). Inhibitory neurons are critical
for maintaining the excitatory-inhibitory balance necessary for
the effective transfer of information while preventing runaway
excitation, and consequently play important roles in regulat-
ing network activity (Pouille and Scanziani, 2001; Markram
et al., 2004; Haider and McCormick, 2009). Severe disruption of
GABAergic inhibition profoundly alters neocortical activity pat-
terns and leads to seizures, while milder changes in inhibitory
neuron number and function are strongly linked to psychiatric
disorders, such as schizophrenia and autism (Volk et al., 2002;
Yau et al., 2003; Belmonte et al., 2004; Levitt et al., 2004; Cossart
et al., 2005; Dani et al., 2005; Caceda et al., 2007; Gonzalez-Burgos
and Lewis, 2008; Morris et al., 2008). Inhibition is thus hypothe-
sized to be a critical regulator of normal brain function and a key
cause of dysfunction in disease. Inhibitory function relies on the
existence of a variety of GABAergic inhibitory neuronal subtypes.
Most inhibitory neurons display locally projecting axons and have
been consequently named interneurons. Besides this morpholog-
ical variety, different classes of inhibitory neurons exhibit distinct
intrinsic membrane properties, molecular markers, connectivity,
and synaptic specializations, and therefore likely mediate spe-
cific roles within cortical circuits (Fishell and Rudy, 2011). In the
murine system, although many characteristics are not acquired
until several weeks postnatally, the specification of GABAergic
neurons in the mature animal is largely established during embry-
onic development, through the function of specific transcription
factors exclusive to different spatial regions (Flames et al., 2004;
Butt et al., 2005, 2008; Wonders and Anderson, 2006; Fogarty
et al., 2007; Wonders et al., 2008; Batista-Brito and Fishell, 2009;
Gelman et al., 2009).
While the majority of neocortical GABAergic neurons project
a highly ramified axon locally, these interneurons are not the sole
source of inhibition within the neocortex. A small portion of
GABAergic neurons projects axons to distant neocortical areas,
including regions in the ipsilateral hemisphere and contralateral
hemispheres (McDonald and Burkhalter, 1993; Gonchar et al.,
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1995; Aroniadou-Anderjaska and Keller, 1996; Chowdhury et al.,
1996; Salin and Prince, 1996; Kimura and Baughman, 1997).
A study combining labeling of GABAergic projection neurons,
retrograde labeling and axon tracing methods revealed that the
vast majority of neocortical long-range projecting GABAergic
neurons belong to a group of cells expressing the neuronal iso-
form of nitric oxide synthase (nNOS) (Tomioka et al., 2005).
This result suggests that even though low in number (Gonchar
et al., 2007), neocortical nNOS GABAergic neurons have the
potential to strongly influence neocortical networks. Most of the
studies on the origin and function of nNOS cells have focused
on the hippocampus where nNOS is expressed in a numerically
large population of GABAergic neurons (Fuentealba et al., 2008;
Tricoire et al., 2010, 2011). However, the function and origin
of nNOS-expressing inhibitory neurons in the neocortex remain
largely unexplored.
Neocortical and hippocampal GABAergic inhibitory neurons
are produced in the neurogenic ganglionic eminences of the
ventral telencephalon (or subpallium) and migrate tangentially
toward the neocortex and hippocampus (Anderson et al., 1997a;
Lavdas et al., 1999; Sussel et al., 1999; Pleasure et al., 2000; Marin
and Rubenstein, 2001; Wichterle et al., 2001). The ventral gan-
glionic eminences express numerous genes known to be essential
for the generation of GABAergic cells. These include genes with
widespread expression throughout the subpallium, such as the
Distaless homeobox (Dlx) family of genes (Dlx1, 2, 5, and 6)
(Anderson et al., 1997a,b; Cobos et al., 2005; Ghanem et al.,
2007; Potter et al., 2009), which have been shown to be criti-
cal for interneuron migration and specification (Anderson et al.,
1997b; Pleasure et al., 2000; Petryniak et al., 2007). Most neo-
cortical and hippocampal GABAergic neurons are produced in
the embryonic proliferative regions named the medial and caudal
ganglionic eminences (MGE and CGE, respectively) (Wichterle
et al., 2001; Nery et al., 2002; Xu et al., 2004, 2008; Butt et al.,
2005; Flames et al., 2007; Fogarty et al., 2007; Miyoshi et al.,
2010; Tricoire et al., 2011), and a smaller percentage are pro-
duced in the embryonic preoptic area (POA) (Gelman et al., 2009,
2011).
In the neocortex, near all parvalbumin (PV) and somatostatin
(SST) expressing inhibitory neuron subtypes are produced in the
MGE (Wichterle et al., 1999; Butt et al., 2005; Fogarty et al.,
2007; Wonders et al., 2008; Xu et al., 2008). The genetic cascade
necessary for proper specification, differentiation, and develop-
ment of MGE-derived interneurons is starting to be elucidated.
Nkx2.1 has been shown to direct the MGE-subtype specification
and Lhx6 is necessary for the proper migration and matura-
tion of both PV- and SST-expressing interneurons (Sussel et al.,
1999; Liodis et al., 2007). The transcription factor Sox6, which is
also expressed in MGE-derived interneuron lineages (Azim et al.,
2009; Batista-Brito et al., 2009), acts downstream of Lhx6 and is
required for the positioning and maturation of PV cells, and to a
lesser extent, SST cells (Batista-Brito et al., 2009).
In addition to the MGE, the CGE is the second largest source
of neocortical inhibitory neurons, contributing approximately
30% of all GABAergic neurons (Lee et al., 2010). Recently, it has
been shown that all CGE-derived neocortical interneurons specif-
ically express the serotonin receptor 3a (5-Ht3a) (Lee et al., 2010;
Vucurovic et al., 2010), while the transcription factors CoupTF1/2
are widely but not selectively expressed within the CGE (Sousa
et al., 2009). The 5-Ht3a-expressing CGE-derived GABAergic
neocortical interneurons, includes the entire vasoactive intestinal
peptide (VIP) and cholecystokinin (CCK)-expressing population
as well as the entire SST-negative populations of calretinin (CR)
and Reelin (RLN)-expressing interneurons (Nery et al., 2002; Lee
et al., 2010; Miyoshi et al., 2010).
It has been recently shown that different parts of the POA
selectively express Nkx5.1 and Dbx1, respectively, and produce
a small and highly diverse fraction of neocortical GABAergic
interneurons (Gelman et al., 2009, 2011). The interneurons types
produced in the Dbx1 population are largely overlapping with
the MGE-derived subtypes while it is possible that the Nkx5.1
expressing population is included in the population expressing
5-Ht3a (Gelman et al., 2009, 2011; Lee et al., 2010).
Similarly to neocortical interneurons, PV- and SST-expressing
hippocampal interneurons originate in the MGE, whereas hip-
pocampal interneurons expressing CCK, CR, and VIP are pro-
duced in the CGE (Tricoire et al., 2011; Keimpema et al., 2012).
Neuropeptide Y (NPY) expressing hippocampal interneurons
encompass a mixed repertoire of subtypes originating from the
MGE, CGE and the POA (Gelman et al., 2009). Despite largely
originating in the MGE, the majority of nNOS-expressing hip-
pocampal GABAergic neuron subpopulations do not overlap with
PV- or SST-expressing interneurons (Fuentealba et al., 2008;
Tricoire et al., 2010, 2011), and few nNOS-positive cells co-
express CR (Jinno and Kosaka, 2002a). In the hippocampus,
nNOS is expressed in the majority of neurogliaform cells (NGC)
and Ivy cells (IvCs) interneuron subtypes (Fuentealba et al., 2008;
Tricoire et al., 2010). Within the hippocampus, nNOS colocal-
izes with a variety of markers (Fuentealba et al., 2008; Szabadics
and Soltesz, 2009; Tricoire et al., 2010) and has been reported
to be the numerically largest interneuron population (Fuentealba
et al., 2008). It remains unknown if there are any homologs of the
nNOS-expressing neurogliaform and Ivy interneurons within the
neocortex.
Here we show that contrary to the hippocampus, nNOS-
expressing cells constitute a small minority of the total neocortical
GABAergic neurons. In order to investigate the developmental
origin of nNOS-expressing cells, we did genetic fate mapping
using cre-drivers specific for different domains of the MGE
(Nkx2.1Cre and Lhx6Cre) as well as the 5-Ht3aEGFP-reporter line
that labels the CGE-derived lineage. Our findings suggest that
nNOS-expressing neocortical GABAergic neurons originate from
the MGE, mainly from the most dorsal domain of the MGE
(dMGE). In the hippocampus, similarly to what has been previ-
ously shown, we observed that a majority of the nNOS interneu-
rons are derived from theMGE, but a significant portion originate
within the CGE and/or POA (Tricoire et al., 2010). Both neocor-
tical and hippocampal nNOS-expressing cells also express NPY,
but in contrast to the hippocampus virtually all neocortical nNOS
neurons express SST, and about half express CR. Finally, we show
that the transcription factor Sox6 has a role in the differentia-
tion of neocortical nNOS cells, since loss of Sox6 leads to a total
absence of SST expression in neocortical nNOS cells, and possibly
stunts the development of neurites.
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Our results show that nNOS-expressing neocortical and hip-
pocampal inhibitory neurons have different origins, suggest-
ing that neocortical and hippocampal nNOS-expressing cells
constitute an example of unrelated subtypes, both having
acquired/retained the expression of nNOS. Understanding the
functional role of this sparse population of neocortical long-range
projection inhibitory neurons and the relevance of the nitrinergic
signaling in cortical circuits are questions of considerable interest.
MATERIALS ANDMETHODS
MOUSE LINES
All animal handling and maintenance were performed accord-
ing to the regulations of the Institutional Animal Care and
Use Committee of the NYU School of Medicine. The Dlx6Cre
(GENSAT project at Rockefeller University), Lhx6Cre (Fogarty
et al., 2007), Nkx2.1Cre (Xu et al., 2008), SSTCre (Taniguchi et al.,
2011), 5-Ht3aEGFP (GENSAT project at Rockefeller University),
Sox6F/+ (Dumitriu et al., 2006), and RCEEGFP (Sousa et al.,
2009) mouse lines were maintained in amixed background (Swiss
Webster and C57Bl/6), and genotyped as previously described
(Stenman et al., 2003; Dumitriu et al., 2006; Fogarty et al., 2007;
Butt et al., 2008; Xu et al., 2008; Taniguchi et al., 2011).
In vivo GENETIC FATE MAPPING
To perform genetic fate mapping of neocortical and hippocam-
pal GABAergic neurons transgenic males heterozygous for the
driver line Dlx6Cre (GENSAT project at Rockefeller University)
were crossed to female homozygous for the RCEEGFP allele
reporter allele (Sousa et al., 2009). To fate map MGE-derived lin-
eages, males heterozygous for the transgenic driver lines Lhx6Cre
(Fogarty et al., 2007) andNkx2.1Cre (Xu et al., 2008) were crossed
to female mice homozygous for the RCEEGFP reporter allele
(Sousa et al., 2009). Fate mapping of the CGE-derived lineage
was accomplished by using the BAC-transgenic line 5-Ht3aEGFP
(GENSAT project at Rockefeller University).
In vivo Sox6 CONDITIONAL LOSS OF FUNCTION
Male Sox6F/+; Lhx6Cre or Sox6F/+ ; SSTCre mice were crossed to
Sox6F/F ; RCEEGFP/EGFP females to generate productive Sox6F/+;
Lhx6Cre ; RCEEGFP (control) and Sox6F/F ; Lhx6Cre ; RCEEGFP
(mutant); or Sox6F/+; SSTCre; RCEEGFP (control) and Sox6F/F ;
SSTCre; RCEEGFP (mutant) offspring.
TISSUE PREPARATION FOR IMMUNOCYTOCHEMISTRY
The brains of juvenile mice (P21) were fixed by transcardiac
perfusion of 4% paraformaldehyde (PFA)/phosphate buffered
saline (PBS) solution followed by a one hour post-fixation on
ice with 4% PFA/PBS solution. Brains were rinsed with PBS and
cryoprotected by using 30% sucrose/PBS solution overnight at
4◦C. Tissues were embedded in Tissue Tek, frozen on dry ice, and
cryosectioned at 20μm thickness.
IMMUNOHISTOCHEMISTRY
Sections for immunohistochemistry analysis were processed
using 2% normal goat serum/0.1% Triton X-100 in all proce-
dures except washing steps, where only PBS was used. Sections
were blocked for 1 h, followed by incubation with the primary
antibodies overnight at 4◦C. Cryostat tissue sections were stained
with the following primary antibodies: rabbit anti-GFP (1:1000;
Molecular Probes), rat anti-GFP (1:1000, Nacalai Tesque),
chicken anti-GFP (1:1000, AbCam), mouse anti-Parvalbumin
(1:1000; Sigma), rat anti-SST (1:500; Chemicon), rabbit anti-NPY
(1:500; Incstar), sheep anti-NPY (1:500; Chemicon), mouse anti-
Reelin (1:500; MBL international), rabbit anti-nNOS (1:1000,
Chemicon), mouse anti-calretinin (1:750; Chemicon). Secondary
antibodies conjugated with Alexa fluoro-dyes 488, 594, or 649
(Molecular Probes) raised from the same host were then used
as blocking serum and were applied for 30min at room tem-
perature for visualizing the signals. Nuclear counterstaining was
performed with 100 ng/ml 4,6-diamidino-2-phenylindole (DAPI)
solution in PBS for 1min. Fluorescent images were captured using
a cooled-CCD camera (Princeton Scientific Instruments, NJ)
using Metamorph software (Universal imaging, Dwoningtown,
PA). For all embryonic and postnatal stages, counting was
performed on a minimum of four coronal sections from at
least two animals using the image processing and analysis
software ImageJ (Wayne Rasband, NIH). Neocortical analyses
were performed in the somatosensory barrel cortex (S1BF).
Hippocampal analyses were carried out in CA3, CA1, and den-
tate gyrus. To minimize counting bias we compared sections of
equivalent bregma positions (from −1.5mm to −2.0mm rel-
ative to bregma), defined according to the Mouse Brain atlas
(Franklin and Paxinos, 2001). All data were represented as
mean ± SEM.
RESULTS
NEOCORTICAL nNOS-EXPRESSING CELLS CONSTITUTE A SMALL
MINORITY OF NEOCORTICAL GABAergic NEURONS
Previous work has shown that nNOS cells in the hippocampus
and neocortex express markers characteristic of inhibitory neu-
rons (Jinno et al., 2002; Gonchar et al., 2007; Fuentealba et al.,
2008). In order to determine the percentage of nNOS neurons
that are GABAergic, as well as the percentage of GABAergic neu-
rons that express nNOSwe performed immunostaining for nNOS
in brain slices where the entire GABAergic cortical neuronal pop-
ulation was labeled with EGFP, using genetic fate mapping of cells
expressing the pan-GABAergic gene Dlx6 (Batista-Brito et al.,
2008). Genetic fate mapping experiments using Cre/loxP tech-
nology are based on the combined use of a driver allele (whereby
the promoter of a gene of interest drives the expression of a Cre
recombinase) and a floxed-reporter allele (whereby the expres-
sion of the reporter gene is triggered by a recombination event
mediated by the Cre recombinase). Upon recombination, the
expression of the reporter gene allows for selective and cumu-
lative labeling of cells sharing the common expression of the
gene of interest at any point in their history. Here we used the
Dlx6Cre driver mouse line combined with the RCEEGFP reporter
line, whereby Cre activity removes the floxed-STOP cassette at
the Rosa locus, resulting in permanent EGFP expression in cells
that have once expressed Dlx6. We show that all the neocortical
and hippocampal interneurons (100 ± 0.9% and 99.5 ± 1.1%,
respectively) expressing nNOS also express EGFP. Therefore, we
conclude that nNOS labeling in the neocortex and hippocampus
is restricted to GABAergic neurons (Figures 1A–C). The number
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FIGURE 1 | Genetic fate mapping reveals that neocortical and
hippocampal nNOS-expressing cells are GABAergic inhibitory neurons.
The inhibitory fate was verified using the pan-interneuronal driver Dlx6Cre
allowing the expression of the EGFP from the RCE reporter in the neocortex
(somatosensory cortex) (A) and hippocampus (B). Using this fate mapping
strategy we determined the percentage of neocortical and hippocampal
GABAergic neurons expressing the neuronal Nitric Oxide Synthase (nNOS) on
telencephalic coronal sections. (A) Representative section showing sparse
cells that express nNOS in the mouse barrel cortex at P21 (arrows), mainly in
superficial (layer II/III) (A1) and deep (layer VI) (A2) layers as shown by the
DAPI counterstaining. Note the presence of EGFP in every nNOS-expressing
cell. A few nNOS-expressing neurons are also located in the white matter
(arrowheads). (B) Scattered nNOS staining is found throughout the mouse
hippocampus at P21, in all layers of the Ammon’s horns CA1–3 (arrows) as
well as in all layers of the dentate gyrus (arrowheads). Similar to the
neocortex and irrespective of the cell’s location within the hippocampus
(B1, hilar region and subgranular layer of the dentate gyrus; B2, CA1
stratum pyramidale and stratum oriens; B3, CA3 stratum radiatum and
stratum lacunosum-moleculare), nNOS-expressing cells are GABAergic
neurons as revealed by the expression of EGFP. (C) Histogram showing the
percentage of nNOS-expressing neurons that are fate mapped by the
Dlx6Cre; RCEEGFP line in mouse cortex and hippocampus (100 ± 0.0% and
99.5 ± 1.1%) (n = 3 independent brains for each genotype). (D) Histogram
showing the percentage of Dlx6Cre; RCEEGFP fate mapped interneurons that
express nNOS in mouse cortex and hippocampus (1.7 ± 0.3% and
15.9 ± 3.2%) (n = 3 independent brains for each genotype). Data represent
mean ± SEM. Scale bars correspond to 100μm (A,B) and 25μm
(A1,A2,B1–3).
of neocortical GABAergic neurons expressing nNOS is much
lower relative to the number of nNOS-expressing cells in the
hippocampus (Figures 1A–C). Within the neocortex only 1.7 ±
0.3% of the total number ofDlx6 fate mapped cells express nNOS,
compared to 15.9 ± 3.2% in the hippocampus (Figure 1D).
All our analyses were confined to cells that express high lev-
els of nNOS, also known as nNOS type I neurons (Yan et al.,
1996; Judas et al., 1999; Lee and Jeon, 2005). For simplicity,
and because the used antibody does not allow the identifi-
cation of cells expressing low levels of nNOS (type II nNOS
neurons), we will refer to the cells that unambiguously express
high levels of nNOS as nNOS-expressing cells throughout the
manuscript. Neocortical nNOS neocortical neurons are prefer-
entially distributed in deeper layers (V–VI), although some are
located in the superficial layers (II/III) (Figure 1A). Furthermore,
a few nNOS-expressing neurons are also located in the white
matter. Neocortical nNOS neurons display highly elaborated pro-
cesses as described elsewhere (Tomioka et al., 2005). By contrast,
nNOS staining is present throughout the mouse hippocampus
at P21, including all layers of the Ammon’s horns CA1-3 as
well as in the dentate gyrus’ layers (except the granular layer)
(Figure 1B).
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THE MAJORITY OF NEOCORTICAL nNOS GABAergic NEURONS
ORIGINATE WITHIN THE dMGE
In order to determine the origin of nNOS-expressing neocorti-
cal inhibitory neurons, we fate mapped neurons produced in the
ventral telencephalon and located in the somatosensory cortex of
P21 mice. Fate mapping of the MGE was accomplished by using
the Nkx2.1Cre (Xu et al., 2008) and Lhx6Cre (Fogarty et al., 2007)
driver lines in combination with the RCEEGFP reporter allele. In
Nkx2.1Cre ; RCEEGFP mice, EGFP labeled cells originate in most
of the MGE (except for its most dorsal part; dMGE), and the
POA (Xu et al., 2008; Sousa et al., 2009). In Lhx6Cre; RCEEGFP
mice cells originating within the entire MGE, and POA are per-
manently labeled with EGFP (Fogarty et al., 2007). Lhx6 is also
expressed in blood vessels, therefore, fate mapping using this line
also labels blood vessels with EGFP (Fogarty et al., 2007). We
labeled CGE-derived cells with the transgenic line 5-Ht3aEGFP
(Lee et al., 2010).
Our results show that nNOS neurons colocalize with
EGFP in the Nkx2.1Cre ; RCEEGFP and Lhx6Cre; RCEEGFP mice
(Figures 2A,B), but not in the 5-Ht3aEGFP animals (Figure 2C).
FIGURE 2 | Neocortical nNOS-expressing inhibitory neurons are derived
from the medial ganglionic eminence. To ascertain and quantify the spatial
origin of cortical nNOS inhibitory neurons, we employed different fate
mapping strategies based on the use of Nkx2.1Cre; RCEEGFP (A), Lhx6Cre;
RCEEGFP (B), or 5-Ht3aEGFP mice (C). (A–C) Representative pictures of
coronal sections of P21 mouse somatosensory neocortex immunolabeled
with EGFP and nNOS. Fate mapped cells expressing EGFP and nNOS are
indicated by arrowheads. Arrows indicated cells expressing nNOS only.
(D,E) Histograms showing the fate mapping of cortical nNOS GABAergic
neurons and the contribution of nNOS-expressing cells to MGE and CGE
populations, expressed as the percentage of nNOS+/GFP+ cells in
the entire nNOS positive population (D), or in the entire EGFP positive
population (E). The Nkx2.1Cre; RCEEGFP fate mapping indicates that
28.5 ± 4.3% of nNOS GABAergic neurons originate from the MGE
domain covered by the Nkx2.1Cre driver line (A,D) and that nNOS cells
account for 0.7 ± 0.2% of this Nkx2.1Cre -derived population (A,E) (n = 3
independent brains). The Lhx6Cre; RCEEGFP and 5-Ht3aEGFP fate
mapping strategies revealed that virtually all nNOS-cINs originate from the
MGE (93.0 ± 3.3%) (B,D) and not from the CGE (no cells co-express nNOS
and GFP) (C,D), respectively (n = 3 independent brains for each genotype).
On the other hand, nNOS cells account for 2.6 ± 1.1% of MGE-derived
inhibitory neurons fate mapped by the Lhx6Cre; RCEEGFP (B,E). Data
represent mean ± SEM. Scale bars correspond to 100μm (A–C) and 25μm
(A1,B1,C1,C2).
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Since 5-Ht3aEGFP labels cells migrating out from the CGE, our
results suggest that the CGE do not produce nNOS inhibitory
neurons of the neocortex.
In contrast, 93 ± 3.3% of nNOS cells in the somatosensory
cortex of Lhx6Cre; RCEEGFP mice express EGFP (Figures 2B,D),
leading us to conclude that the vast majority of the neocor-
tical nNOS cells originate within the MGE. Surprisingly, only
28.5 ± 4.3% of nNOS cells also express EGFP when we used the
Nkx2.1Cre ; RCEEGFP transgenic line. Comparison of the results
from the Nkx2.1Cre ; RCEEGFP and Lxh6Cre; RCEEGFP lines indi-
cate that 70–75% of the total of nNOS cells in the somatosen-
sory cortex originates within the dMGE, while the remaining
20–25% originates from the Nkx2.1Cre domain. Moreover, this
fate mapping strategy also confirmed that nNOS inhibitory neu-
rons only account for a small portion of the MGE- and dMGE-
derived cortical interneurons (respectively, 0.7 ± 0.19% of fate
mapped interneurons in Nkx2.1Cre ; RCEEGFP mice and 2.6 ±
1.1% of fate mapped interneurons in Lhx6Cre; RCEEGFP mice)
(Figure 2E).
HIPPOCAMPAL nNOS GABAergic NEURONS DO NOT ORIGINATE
WITHIN THE dMGE
We used the fate mapping approaches previously described to
test if hippocampal nNOS neurons have the same origin as their
neocortical counterparts. In accordance with previous studies
(Tricoire et al., 2010), we observed that the majority of hip-
pocampal nNOS neurons are derived from the MGE, as indi-
cated by the observation that 76.5 ± 1.9% and 77.9 ± 5.7%
of nNOS inhibitory neurons coexpress EGFP in the transgenic
linesNkx2.1Cre ;RCEEGFP (Figures 3A–C,J) and Lxh6Cre; RCEEGFP
(Figures 3D–F,J), respectively. Comparison of the results from
the Nkx2.1Cre ; RCEEGFP and Lxh6Cre ; RCEEGFP lines indicate that,
contrary to what is observed in the neocortex, only a small minor-
ity (less than 2%) of hippocampal nNOS cells originate from
the dMGE. Furthermore, we observed in the hippocampus that
43.1 ± 0.4% of nNOS neurons were co-labeled with EGFP in the
transgenic 5-Ht3aEGFP line (Figures 3G–I,J). While it has been
previously recognized that the CGE produces some hippocampal
nNOS neurons by using the transgenic lines Gad65GFP (Tricoire
et al., 2010) and Mash1CreER (Tricoire et al., 2010), the contribu-
tion of the CGE towards nNOS hippocampal neurons perhaps
have been underestimated. This could be due to the fact that the
Gad65GFP lineage does not recapitulate the totality of the CGE-
derived lineage of interneurons, and due to the mosaic inducible
nature of the Mash1CreER line. However, the fact that 77.9 ± 5.7%
(from the Lhx6Cre) and 43.1 ± 0.4% (from 5-Ht3aEGFP) adds up
to more than a 100% it is likely that 5-Ht3aEGFP is less a spe-
cific CGE-marker in the hippocampus compared to the cortex.
Another possible explanation, which is not mutally exclusive of
these observations, is that cell arising in the POA are both EGFP-
positive in the Lhx6Cre; RCEEGFP and in the 5-Ht3aEGFP lines in
the hippocampus. If the latter is the case, up to 21% of the nNOS
population could be POA-derived, a much higher number than
in the cortex.
Moreover, this fate mapping analysis in the hippocampus
revealed that nNOS inhibitory neurons account for 39.4 ± 0.9%
ofNkx2.1Cre ; RCEEGFP fate mapped cells, 23.6 ± 5.4% of Lhx6Cre ;
RCEEGFP fate mapped cells and 15.1± 4.5% of of 5-Ht3aEGFP fate
mapped cells (Figure 3K).
Interestingly, we observed that despite the striatum being typ-
ically thought of as a structure less related to the neocortex
than the hippocampus, the origins of striatal and neocortical
nNOS cells are more similar than the origins of hippocampal
and neocortical nNOS cells. The vast majority of striatal nNOS
cells originate from the MGE, as indicated by Lhx6Cre fate map-
ping (Compare Figure 4A to B, Figure 4C) (Gittis et al., 2010).
Similarly to the neocortex, the dMGE is a major source of striatal
nNOS neurons, producing about 40% of this population (sub-
stract 45.9% of nNOS cells fate-mapped with the line Nkx2.1Cre ;
RCEEGFP to 86.7% of nNOS cells fate mapped with the line
Lhx6Cre ; RCEEGFP) (Figure 4C).
NEOCORTICAL nNOS NEURONS BELONG TO THE MGE-DERIVED
SOMATOSTATIN-POSITIVE POPULATION OF GABAergic
INHIBITORY NEURONS
In order to eludicate the neurochemical profile of the dMGE-
derived nNOS-expressing inhibitory neurons, we performed
immunostaining for nNOS and SST, PV, NPY, CR, and RLN,
which are characteristic markers of inhibitory neuron subtypes.
Double immunostaining performed with the antibodies nNOS
and SST or PV in the juvenile somatosensory mouse cortex (P21)
shows that virtually all nNOS cells co-express SST but not PV
(data not shown). A further genetic fate mapping analysis carried
out using the SSTCre; RCEEGFP line confirmed that all neocor-
tical nNOS cells belong to the SST-expressing population, and
none of them express PV (Figures 5A,B). In addition, we did
triple labeling, to discern between the SST/CR and SST/RLN co-
expressing populations versus the STT-negative/CR and /RLN
expressing cells that are CGE-derived (Rudy et al., 2011).
It is worth mentioning that NPY expression also seems to be
shared by subpopulations of several different non-overlapping
subtypes that have been shown to originate from the MGE, CGE,
and POA (Fogarty et al., 2007; Xu et al., 2008; Gelman et al., 2009;
Lee et al., 2010; Miyoshi et al., 2010). All the nNOS/SST dou-
ble positive cells also co-express NPY (Figures 5B,C), 60 ± 15%
express CR (Figures 5B,D), and none of the nNOS/SST double
positive cells expressed RLN (Figures 5B,E). This is in contrast
to the SST population in general, among which only around
25% co-express CR. This further supports a dorsal MGE ori-
gin for nNOS neocortical neurons since this population has been
shown to also be enriched in SST/CR double positive interneu-
rons (Sousa et al., 2009). In contrary, themajority of hippocampal
nNOS cells do not express SST (Figure 5F), except for a small
proportion of nNOS interneurons, mainly located in the den-
tate gyrus hilus (Figure 5F1). Interestingly, virtually all the striatal
nNOS neurons also express SST (Figure 5G), once again suggest-
ing that striatal, but not nNOS hippocampal neurons, are related
to nNOS neocortical neurons in terms of origin and phenotype.
THE TRANSCRIPTION FACTOR Sox6 IS REQUIRED FOR THE
SPECIFICATION OF NEOCORTICAL nNOS GABAergic NEURONS
We have previously shown that the transcription factor Sox6 is
present in most if not all MGE-derived neocortical inhibitory
neurons (Batista-Brito et al., 2009). Sox6 expression is dependent
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FIGURE 3 | Hippocampal nNOS-expressing inhibitory neurons are not
generated from the dMGE. To ascertain and quantify the spatial origin of
nNOS inhibitory neurons scattered through the entire hippocampus (CA1–3
and dentate gyrus), we employed different fate mapping strategies based on
the use of Nkx2.1Cre; RCEEGFP (A–C), Lhx6Cre; RCEEGFP (D–E), or 5-Ht3aEGFP
mice (F–H). (A,D,G; B,E,H; C,F,I) Representative pictures of EGFP and nNOS
immunolabeled P21 mouse hippocampus that illustrate the CA1, CA3 and
dentate gyrus, respectively. Although MGE-derived nNOS GABAergic
neurons are found in the different layers of the CA1 and CA3 regions, they are
mostly found in the hilus and subgranular layer of the dentate gyrus (A,B,D,E)
but are absent from the granular layer (C,F). Similarly, CGE-derived nNOS
cells are located in the different layers of CA1, CA3 (G,H) and dentate gyrus,
with the exception of the dentate gyrus granular layer (I). (J,K) Histograms
showing the fate mapping of hippocampal nNOS GABAergic neurons and the
contribution of nNOS-expressing cells to MGE- and CGE-derived populations
of hippocampal inhibitory neurons. The Nkx2.1cre ; RCEEGFP and Lhx6Cre;
RCEEGFP fate mappings indicates that 76.5 ± 1.9% and 77.9 ± 5.7% of nNOS
GABAergic neurons originate from the MGE domains covered by the
Nkx2.1Cre or Lhx6Cre driver lines, respectively (J). Note that comparable
numbers of nNOS inhibitory neurons are fate mapped by both Nkx2.1Cre or
Lhx6Cre driver lines suggesting that the dMGE is not an origin for
hippocampal nNOS inhibitory neurons. By contrast, the nNOS cells account
for 39.4 ± 0.9% and 23.6 ± 5.4% of the Nkx2.1Cre - and Lhx6Cre -derived
population, respectively (K). The 5-Ht3aEGFP fate mapping strategy revealed
that 43.1 ± 0.4% of nNOS inhibitory neurons originate from the CGE. While
conversely, nNOS GABAergic neurons account for 15.1 ± 4.5% of
CGE-derived inhibitory neurons fate mapped by the 5-Ht3aEGFP . a, alveus;
o, stratum oriens; p, stratum pyramidale; r, stratum radiatum; m, molecular
layer; g, granular layer; h, hilus. Data represent mean ± SEM (n = 3
independent brains for each genotype). Scale bar corresponds to 100μm.
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FIGURE 4 | Striatal nNOS GABAergic neurons are derived from the
entire MGE. To determine and quantify the spatial origin of nNOS
GABAergic neurons present in the striatum, we performed fate mapping
experiments based on the use of Nkx2.1Cre; RCEloxP (A), and Lhx6Cre;
RCEEGFP (B). This set of experiments revealed that 45.9 ± 10.5% and
86.7 ± 1.7% of nNOS GABAergic neurons originate from the MGE domains
covered by the Nkx2.1Cre or Lhx6Cre driver lines, respectively (C). Data
represent mean ± SEM (n = 3 independent brains for each genotype).
Scale bar corresponds to 50μm.
on the activity of the transcription factor Lhx6, which is specifi-
cally expressed in all MGE-derived interneurons (Du et al., 2008).
We reported that conditionally removing Sox6 in MGE interneu-
rons leads to a 30% reduction of the number of neocortical neu-
rons expressing SST, and a complete loss of SST/CR-expression in
mutant cells. In the present study, to address if in Sox6 mutants
the nNOS subtype was among the affected SST population,
we removed Sox6 from neocortical MGE-derived interneurons
while simultaneously fate mapping the cells. To this end we used
a conditional allele of Sox6 (Sox6F/F) (Dumitriu et al., 2006)
crossed with the Lhx6Cre driver line and the RCEEGFP reporter
line. The conditional mutant and control generated are Sox6F/F ;
Lhx6Cre; RCEEGFP and Sox6F/+; Lhx6Cre ; RCEEGFP , respectively.
In Sox6F/F ; Lhx6Cre ; RCEEGFP mutants we could still identify
nNOS neurons, however, nNOS somatic expression appeared
to be diminished relatively to control animals (Figures 6A,B).
While the total number of neocortical nNOS neurons tends to
be slightly decreased in control vs mutant (4.8 ± 1.8 nNOS+
cells/mm2 vs 3.4 ± 2.1 nNOS+ cells/mm2, respectively), nNOS
cells were rarely found in the superficial layers of Sox6 conditional
mutants. We next asked if the neurochemical markers NPY, SST,
and CR were affected in neocortical mutant nNOS neurons. The
somatic nNOS staining, in combination with the EGFP expres-
sion of fate mapped cells allowed for the identification of Sox6
mutant MGE-derived inhibitory neurons. Sox6 mutant nNOS
neurons no longer express SST (Figure 6C) or CR (Figure 6D),
but do retain the expression of NPY (Figure 6E). While cortical
nNOS expressing neurons are affected by the conditional loss of
Sox6, their hippocampal counterparts remain largely unaffected
in the conditional Sox6 mutants (data not shown). In agreement
to what we reported previously (Batista-Brito et al., 2009), we
observed a non-cell autonomous increase in the number of cells
expressing NPY, as well as a diffuse and non-cell autonomous
increase in the background of nNOS staining (data not shown).
Furthermore, the cell morphology of mutant nNOS cells seemed
to be severely affected, with these cells possessing considerably
less dendritic and axonic arborization (compare Figures 6A1 and
6B1). However, it is not clear if this represents an alteration
in the morphology of the cells, or if it is the result of weaker
immunostaining. A more careful characterization, such as fill-
ing the mutant cells with a dye will be necessary to resolve this
issue. However, since this cell population is so sparse, we did
not succeed in identifying nNOS cells for detailed morphological
analysis.
As previously described, Sox6F/F ; Lhx6Cre ; RCEEGFP mutants
develop generalized seizures by P16 followed by death of the
animals between P17 and P19 from prolonged seizures, most
likely due to a severe loss of inhibition from the affected PV-
expressing basket cells (Batista-Brito et al., 2009). To test if the
phenotype observed in nNOS cells was a non-cell autonomous
consequence of seizure activity, we generated the mutant mice,
Sox6F/F ; SSTCre; RCEEGFP, in which Sox6 is only removed in
SST-expressing MGE-derived inhibitory neurons, leaving the PV
interneurons unaffected. Sox6F/F ; SSTCre; RCEEGFP mice appear
to be phenotypically normal and do not show premature death
nor develop obvious seizures.We confirmed that similarly to what
we observed in Sox6F/F ; Lhx6Cre ; RCEEGFP mutants, nNOS neo-
cortical neurons in Sox6F/F ; SSTCre; RCEEGFP animals still fail to
express SST and CR (data not shown) and have reduced nNOS
expression at the soma level (Figures 6F,G), as well as seemingly
less elaborated arborization of their processes (Figures 6F1,G1).
Our results suggest that the transcription factor Sox6 is necessary
for the proper specification of nNOS neocortical neurons, and
possibly necessary for the development of complex arborization
of their processes (Figure 7).
DISCUSSION
In the present study, we characterized the contribution of nNOS-
expressing cells in cortical GABAergic populations, as well as
their place of origin and genes involved in their development. We
show that contrary to the hippocampus, where nNOS interneu-
rons are a numerous GABAergic class, nNOS (type I) neurons
in the neocortex only constitute a very small portion of the
GABAergic population. In accordance with previous studies, we
observed that the majority of hippocampal nNOS GABAergic
neurons originate within the MGE (Tricoire et al., 2010, 2011),
however, a considerable percentage of this neuronal type also
arises from the more ventral structures CGE and/ or POA. In con-
trast, the vast majority of neocortical nNOS GABAergic neurons
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FIGURE 5 | Neocortical nNOS+ cells belong to the medial
ganglionic eminence-derived somatostatin population of interneurons.
Use of the SSTCre driver in combination with the RCE reporter allows the
identification of the SST-expressing population of inhibitory neurons both in
the neocortex and the hippocampus. MGE-derived interneurons represent
∼70% of the entire interneuron population and express either somatostatin
(SST) (∼30%) or parvalbumin (PV) (∼40%). Immunostaining using those two
markers permits visualization of the entire population of inhibitory neurons
that come from the MGE. (A) The entire number of nNOS cells (red) in
SSTCre; RCEEGFP P21 somatosensory cortex also expressed GFP
(arrows) but not PV (blue only), either in deep or superficial (A1) layers.
(B–E) Histograms and representative pictures of triple stainings performed
on the SSTCre; RCEEGFP P21 somatosensory cortex to determine the
proportion of nNOS cells co-expressing neurochemical markers found in the
SST-expressing population of inhibitory neurons, such as Neuropeptide Y
(NPY), Calretinin (CR), Reelin (RLN). The entire neocortical nNOS cells
population belongs to the MGE-derived SST-expressing population of
GABAergic neurons and account for 4.1 ± 0.8% of it (data not show).
Moreover, 100% of SST+/nNOS+ neurons co-express NPY, 60 ± 15%
co-express CR, and none of them co-express RLN. (F) To determine if
hippocampal nNOS neurons belong to the MGE-derived SST-expressing
population of inhibitory neurons, we performed immunolabeling of nNOS
and EGFP on SSTCre; RCEEGFP P21 hippocampus. Only a small number of
nNOS neurons express EGFP (arrowheads) in SSTCre; RCEEGFP P21
hippocampus, thus revealing their inclusion in the SST-expressing population
of MGE-derived interneurons. This scarce population, as compared to the
majority of nNOS neurons that do not express GFP (arrows), is most
consistently found in the dentate gyrus hilus (F1) (F1, hilar region and
subgranular layer of the dentate gyrus; F2, CA1 stratum oriens, pyramidale
and radiatum). (G) To determine if striatal nNOS neurons belong to the
MGE-derived SST-expressing population of interneurons, we performed
immunolabeling of nNOS and EGFP on SSTCre; RCElEGFP P21 striatum and
revealed that about 93% of nNOS expressing striatal neurons belong the
SST-expressing population. Data represent mean ± SEM (n = 3 independent
brains). Scale bars correspond to 100μm (A,C–E,F,G) and 25μm
(A1,C1–E1,F1,F2).
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FIGURE 6 | Conditional removal of the transcription factor Sox6
affects the nNOS-expressing population of neocortical GABAergic
inhibitory neurons. The Lhx6Cre driver line is used to conditionally
inactivate Sox6 in MGE-derived GABAergic neurons and simultaneously
fate map the recombined population. (A,B) The expression of nNOS
and their axonal and dendritic arborization are affected within the population
of nNOS+/GFP+ cells (arrowheads) in the P21 somatosensory mouse cortex
of Sox6 mutants (Lhx6Cre ; Sox6F/F ; RCEEGFP ) (B–B1) vs. control (Lhx6Cre ;
Sox6F/+; RCEEGFP ) (A–A1). Note the absence of nNOS-expressing neurons
in superficial layers (II/III), the weaker intensity of nNOS staining in deep
layers (V/VI) of Sox6 mutants vs. control (compare A1 and B1), as well
as the absence of nNOS-containing neurites spanning the entire cortical
thickness in Sox6 mutants vs. control (compare close-up insets in A1
and B1). (C–E) To determine if the removal of Sox6 in nNOS cells affects their
specification, we performed triple staining of EGFP, nNOS (red) in
combination with SST, CR, or NPY (blue). This revealed that
nNOS-expressing inhibitory neurons no longer express SST and CR in
Sox6 mutants (arrowheads) (C,D). However, NPY expression is unaffected in
Sox6 mutants (arrows) (E). (F,G) To exclude any non-cell autonomous effect
on the phenotype, we sought to determine if the SSTcre removal of Sox6
recapitulates the phenotype observed upon Lhx6cre removal of Sox6.
EGFP/nNOS double staining of P21 somatosensory cortex revealed that
MGE-derived SST/nNOS-expressing GABAergic neurons (arrowheads) are
consistently affected by the loss of Sox6, as evidenced by the absence of
nNOS cells in layer II/III, the decreased intensity of nNOS labeling in layer
V/VI and the absence of nNOS+ neurites in the cortex. Data represent
mean ± SEM (n = 3 independent brains for each genotype). Scale bars
correspond to 100μm.
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FIGURE 7 | Sox6 loss-of-function phenotype in nNOS neocortical
inhibitory neurons. Removal of Sox6 in nNOS neocortical inhibitory neurons
leads to the absence of SST expression, decreased levels of nNOS in the
soma and absence of nNOS-expression in neurites, which are no longer
visible. It remains to be determined whether the inability to detect neurites is
caused by their truncation, or due to weak nNOS-expression.
are produced in the MGE, mainly in the dMGE. Hippocampal
nNOS GABAergic neurons are also more diverse than their neo-
cortical counterparts with regards to their molecular heterogenity.
Neocortical nNOS cells appear to be a rather homogeneous
population consisting perhaps of only two sub-populations. All
nNOS-expressing neocortical inhibitory neurons express SST
and NPY while 60% of them express CR. However, hippocam-
pal nNOS GABAergic neurons express a variety of molecular
markers such as NPY, SST, VIP, CR (Tricoire et al., 2010), and
can further be subdivided on neurogliaform cells (NGC) and
Ivy cells (IvC) accordingly to their morphology and the lami-
nar location on their soma (Fuentealba et al., 2008). Finally we
show that while neocortical nNOS cells require the transcrip-
tion factor Sox6 in order to develop their mature morphology
and express characteristic molecular markers, the maturation of
the hippocampal nNOS cells appears to be unaffected by Sox6
loss of function. This again strengthens the evidence support-
ing that nNOS GABAergic neurons in these two distinct, but
highly related cortical structures, are generated through indepen-
dent developmental programs. Interestingly neocortical nNOS
neurons appear to be more closely related to their striatal coun-
terparts.
NEOCORTICAL nNOS GABAergic NEURONS MAINLY ORIGINATE
IN THE DORSAL MGE
Neocortical GABAergic neurons arise from three telencephalic
transient embryonic structures, the MGE, CGE, and POA
(Batista-Brito and Fishell, 2009). In Figure 8, we show a
schematic of genes expressed in those regions, which are impor-
tant for the production and specification of neocortical and
hippocampal GABAergic neurons. The MGE expresses Nkx2.1
(Sussel et al., 1999) (red domain in Figure 8). In order to fate map
the MGE we used the BAC line Nkx2.1Cre, in which Cre expres-
sion is driven by the Nkx2.1 promoter (Xu et al., 2008). While
Nkx2.1 protein is expressed throughout the MGE and POA, Cre
expression in the Nkx2.1Cre driver spares the most dorsal part
of the MGE (dMGE) (purple domain in Figure 8) (Xu et al.,
2008). The absence of Cre expression in the dMGE of this BAC
transgenic line might be due to positional effects or the absence
of a critical part of the Nkx2.1 promoter. However, because the
expression of Nkx2.1 mRNA is weaker in the dMGE than the
rest of the MGE (Sussel et al., 1999), it has been suggested that
the absence of Cre expression in the dMGE reflects a weaker
Nkx2.1 gene activation in this domain (Xu et al., 2008). The fact
that the expression of another independently producedNkx2.1Cre
BAC line is also absent from the dMGE (Kessaris et al., 2006;
Fogarty et al., 2007) further supports this idea. Fate mapping of
the totality of the MGE can be accomplished by using the BAC
transgenic line Lhx6Cre (Fogarty et al., 2007). Lhx6 is expressed
in postmitotic neurons derived from the MGE, as well as the
POA (blue domain in Figure 8) (Fogarty et al., 2007; Du et al.,
2008).
The most significant insight into the developmental origin of
neocortical nNOS GABAergic was provided by the comparison
between the fate mapping of Nkx2.1- and Lhx6-derived lineages.
A minority of the neocortical nNOS cells (about 30%) could be
accounted byNkx2.1 fate mapping, but virtually all of the neocor-
tical nNOS cells could be accounted by Lhx6 fate mapping (about
95%). Since the only progenitor region labeled by Lhx6 but not
Nkx2.1- fate mapping is the dMGE, our data strongly suggests
that the dMGE is the source of the majority of neocortical nNOS
neurons.
In our experience, no nNOS-positive neocortical neurons were
labeled by the 5-Ht3aEGFP line, which labels the CGE and possibly
part of the POA (Lee et al., 2010). Given that previous studies have
shown that a small fraction of the cortical nNOS-expressing cor-
tical neurons originate in the Dbx1 domain of the POA (Gelman
et al., 2009, 2011), we conclude that the 5-Ht3aEGFP BAC trans-
genic allele is unlikely expressed in the Dbx1-positive domain
within the POA. This is further supported by the presence of
markers typical for MGE (and thus not 5-Ht3aEGFP) such as PV
and SST in the Dbx1-fate mapped population.
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FIGURE 8 | Gene expression in the subpallial proliferative
regions. Schematic representation of coronal sections of an E12.5 brain
illustrating the gene expression profile of the progenitor regions MGE, CGE
and POA. The most frontal section in the anterior/posterior axis (upper-left
section) only comprises the MGE, the middle section contains the MGE,
CGE and the POA, while the most caudal section (lower-right section) only
shows the CGE. The MGE expresses Nkx2.1 (red domain), however, the BAC
line Nkx2.1Cre expresses the Cre recombinase in most of the MGE, except
for its most dorsal part (dMGE) (purple domain). Nkx2.1 and Cre in the line
Nkx2.1Cre are also expressed in some of the POA. Consequently, fate
mapping with the line Nkx2.1Cre labels cells originating from the majority of
the MGE, except for the dMGE (purple domain), and some of
the POA, that migrate into the dorsal telencephalon (light-red arrow).
Lhx6 is downstream of Nkx2.1 and is expressed in postmitotic neurons
originating from the MGE and part of the POA. Fate mapping with the
Lhx6Cre line labels cells derived from the MGE (including dMGE-purple
domain) and part of the POA that migrate into the dorsal telencephalon
(blue arrow). The CGE and part of the POA express 5-Ht3a (green domain).
Fate mapping with the BAC line 5-Ht3aEGFP labels cells arising from the CGE
and part of the POA that migrate into the dorsal thelencephalon (green
arrow). Specific domains of the POA also express Nkx5.1 (gray) and
Dbx1 (orange).
DIVERSE ORIGINS OF nNOS NEOCORTICAL AND HIPPOCAMPAL
GABAergic NEURONS AND THE USE OF NEUROCHEMICAL MARKERS
Fate mapping studies have shown that the neocortical interneu-
ron subtypes arising from the MGE and CGE are, for the most
part, mutually exclusive (Rudy et al., 2011). For instance the
hippocampal and neocortical PV-expressing fast spiking basket
cells are solely produced in the MGE (Butt et al., 2005; Tricoire
et al., 2011), while the CGE is the source of the VIP-expressing
bipolar interneuron populations (Butt et al., 2005; Lee et al., 2010;
Tricoire et al., 2011). This suggests that interneuron precursors
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are subjected to distinct genetic programs initiated within the
eminences that at least in part, determine their subtype identity.
However, some molecular markers, such as the neurotransmitter
NPY, are not specific for a particular interneuron subtype. Both
neocortical and hippocampal NPY-expressing inhibitory neurons
comprise a wide variety of subtypes (Karagiannis et al., 2009;
Tricoire et al., 2011) and are derived from the MGE, CGE, and
POA (Fogarty et al., 2007; Gelman et al., 2009; Lee et al., 2010;
Tricoire et al., 2011). Furthermore, the level of expression of
NPY is highly dependent on neuronal activity (Sperk et al., 1992;
Schwarzer et al., 1995; Baraban et al., 1997). Taken together, these
observations suggest that NPY should be used with caution as a
marker of subtype identity.
Here we show that similar to PV neurons, neocortical nNOS
cells are solely derived from the MGE and constitute a rather
homogeneous subset of long range projections SST-expressing
neurons (Tomioka et al., 2005), therefore, suggesting that in the
neocortex nNOS might be a good indicator of neuronal sub-
type. By contrast, hippocampal nNOS cells are produced from
a number of subpallial regions, have different morphologies and
express a variety of neurochemical markers (Tricoire et al., 2010,
2011). This suggests that using nNOS as a subtypemarkermust be
done carefully, especially when comparing structures. Moreover,
the comparison between subtype diversity of hippocampal and
neocortical cells expressing nNOS suggests that the location of
birth of nNOS neurons is not the sole factor determining their
marker expression, and that environmental cues present in the
neocortex and hippocampus likely influence the expression of
nNOS. It is likely that, except for nNOS expression, neocorti-
cal and hippocampal nNOS neurons are unrelated, and involved
in different functions. Interestingly, neocortical nNOS neurons
appear to have more in common with their counterparts in the
striatum. Although being the largest striatal subtype, nNOS neu-
rons are largely derived from the Nkx2.1 domain and similar to
the cortex express both SST and NPY.
THE TRANSCRIPTION FACTOR Sox6 IS REQUIRED FOR THE
SPECIFICATION OF NEOCORTICAL nNOS GABAergic NEURONS
Previous work has shown that loss of function of Nkx2.1 at
the progenitor level results in a decreased number of nNOS-
expressing neurons migrating tangentially into the cortex during
development (Anderson et al., 2001), and a vast reduction of
nNOS interneurons in the hippocampus at adult ages (Tricoire
et al., 2010). We have previously shown that loss of the tran-
scription factor Sox6, a gene downstream of Nkx2.1 and Lhx6
affects the radial migration and maturation of PV- and to a lesser
extent SST-expressing neocortical inhibitory neurons. PV expres-
sion in fast-spiking basket cells is by and large lost in Sox6mutants
while the effect on SST expression is much more modest. One
SST-positive population that is affected by the loss of Sox6 is the
SST/CR double positive population where CR expression is lost
completely (Batista-Brito et al., 2009). Given that in the neocor-
tex nNOS neurons constitute a subpopulation of SST-neurons, we
investigated whether the neurochemical characteristics, number,
positioning or morphology of nNOS cells would be affected when
Sox6 is conditionally removed in Lhx6 expressing cells. Removal
of Sox6 had a marked effect on nNOS expressing neocortical
inhibitory neurons. While nNOS persists (at low but detectable
levels), Sox6 mutant nNOS-expressing cells no longer express SST
or CR, and are possibly less numerous, as indicated by the fact
that in mutant animals nNOS neocortical neurons tend to be
absent from the superficial layers. Furthermore, it appears based
on nNOS staining, that mutant nNOS neurons display underde-
veloped arborization of their processes. This contrasts with our
previous results showing that even though Sox6 mutant PV cells
are immature, they still develop normal morphology (Batista-
Brito et al., 2009). Taken together, our data show that removal
of Sox6 in nNOS neocortical neurons compromises their specifi-
cation and also perhaps their morphology. Since the phenotype of
nNOS mutant cells remained the same when Sox6 was selectively
removed in SST-expressing neurons, we argue that the effect is cell
autonomous, or at least not caused by disrupted cortical network
activity associated with PV-expressing fast spiking interneuron
dysfunction. Similar to the neocortex, nNOS cells deprived of
Sox6 gene function in the striatum have reduced SST staining
(data not shown). However, we did not detect any obvious defects
in hippocampal nNOS interneurons in Sox6 mutants (data not
shown).
FUNCTIONAL ROLE OF nNOS GABAergic NEURONS
In the hippocampus (Jinno and Kosaka, 2002b), and likely in
the neocortex, nNOS-expressing GABAergic neurons are the
major source of nitric oxide (NO). NO regulates synaptic plas-
ticity of glutamatergic and GABAergic synapses (Garthwaite and
Boulton, 1995; Arancio et al., 1996; Burette et al., 2002; Szabadits
et al., 2007; Garthwaite, 2008), and in the hippocampus poten-
tiates GABA release (Li et al., 2002; Yu and Eldred, 2005).
Even though neocortical nNOS neurons are distinct, and pos-
sibly differently regulated than their hippocampal counterparts,
nNOS cells in the neocortex also function to control the level
of GABA release and synaptic plasticity (Hardingham and Fox,
2006; Dachtler et al., 2011). While the number of nNOS neu-
rons in the neocortex is small, their impact on the neocortical
network through NO release might be significant as they are
highly ramified, and project long distances rostro-caudally and
medio-laterally, connecting neocortical areas up to 6–8mm apart
(Tomioka et al., 2005). In fact, it has been recently shown that
specifically damaging nNOS neurons in the neocortex results
in dysinhibition of the entire neocortical network and strong
alterations of the spatio-temporal dynamics of the neocortex
(Shlosberg et al., 2012). Cortical nNOS expressing neurons are
also implicated in regulating local blood flow by transforming
neuronal signals into vascular responses (Cauli et al., 2004), sug-
gesting that neurogliaform-like neurons that express nNOS are
likely to mediate cortical vasodilatations and/or vasoconstric-
tions that happen in vivo (Karagiannis et al., 2009). Moreover,
it has also been shown that nNOS neurons are active dur-
ing sleep (Gerashchenko et al., 2008). It has been reported
that the functional activation of nNOS neurons during sleep
is restricted to the cortex (Pasumarthi et al., 2010), suggest-
ing that neocortical nNOS are major players in homeostatic
sleep regulation (Gerashchenko et al., 2008; Pasumarthi et al.,
2010). Importantly, while the regulation of the levels of NO is
critical, an excessive production of NO can lead to neurotoxicity
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(Dawson and Dawson, 1998), suggesting that the nNOS
population in addition to normal brain function can result in
disease states when perturbed.
In the future, in order to understand the contribution of
nNOS expressing inhibitory neurons in the neocortical circuit,
it would be interesting to investigate the intrinsic properties of
nNOS neocortical neurons, as well as their synaptic inputs and
outputs. However, in order to address these questions in such
a sparse neuronal type, it will be necessary to specifically target
nNOS cells, a goal that is achievable using recently developed
genetic tools, such as the inducible Cre-diver line, nNOScreER
(Taniguchi et al., 2011). It would be particularly interesting to
compare the electrophysiological properties of nNOS neocortical
neurons to those of other SST expressing cells. Our hypothesis
is that similar to nNOS cells in the striatum (Kawaguchi et al.,
1995; Centonze et al., 2002) and SST neocortical interneurons
(Kawaguchi and Kubota, 1996), nNOS cells in the neocortex will
exhibit low threshold-spiking characteristics. However, due to the
very different range of their output domains, we suspect that their
functional roles in the network may be very different from those
of SST+/nNOS− neocortical interneurons. To address the func-
tional role of neocortical nNOS neurons at both synaptic and
circuit levels, it would be very interesting to selectively activate
and suppress their activity using genetic methods such as opto-
or pharmaco-genetics.
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